Get the Stockscreener App
4.46
0.45%
0.02
Bluejay Diagnostics Inc stock is traded at $4.46, with a volume of 80,346.
It is up +0.45% in the last 24 hours and up +159.30% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
See More
Previous Close:
$4.44
Open:
$4.48
24h Volume:
80,346
Relative Volume:
0.07
Market Cap:
$4.61M
Revenue:
-
Net Income/Loss:
$-6.90M
P/E Ratio:
-0.3182
EPS:
-14.0152
Net Cash Flow:
$-6.65M
1W Performance:
-5.91%
1M Performance:
+159.30%
6M Performance:
+25.82%
1Y Performance:
-30.75%
1-Day Range:
$4.30
$4.86
1-Week Range:
$4.24
$4.93
52-Week Range:
$1.6233
$16.68
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
4.46 | 4.61M | 0 | -6.90M | -6.65M | -14.02 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
BJDX SEC FilingsBluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Bluejay Diagnostics | SCHEDULE 13D: Others - Moomoo
Bluejay Diagnostics Inc (BJDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bluejay Diagnostics Inc (BJDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bluejay Diagnostics Inc (BJDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bluejay Diagnostics Inc (BJDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bluejay Diagnostics Inc (BJDX) Institutional Confidence - TradingKey
Bluejay Diagnostics (NASDAQ: BJDX) registers 11.2M resale shares from warrant holders - Stock Titan
Bluejay Diagnostics Inc (BJDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bluejay Diagnostics Inc (BJDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bluejay Diagnostics Inc (BJDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bluejay Diagnostics Inc (BJDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BJDX Q4 2023 Earnings: Wider-than-Expected Loss Deepens as Pre-Revenue Diagnostics Firm Navigates Cost PressuresEarnings Call Q&A - newsline.com
Bluejay Diagnostics Inc. (BJDX) Q4 2023 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineLong-Term Guidance - newsline.com
BJDX Q4 2023 Earnings: EPS Misses Estimates by Wide Margin as No Revenue ReportedFull Year Guidance - newsline.com
BJDX Q4 2023 Earnings: Significant EPS Miss Amid Pre-Revenue StageMargin Guidance - newsline.com
Bluejay Diagnostics Shareholders Approve Stock Plan and Flexibility - TipRanks
Bluejay Diagnostics (NASDAQ: BJDX) expands stock plan and wins reverse split approval - Stock Titan
BLUEJAY DIAGNOSTICS INC (BJDX) Stock Chart - ChartMill
Bluejay Diagnostics Completes Private Placement to Extend Runway - TipRanks
Bluejay Diagnostics Raises $7.7 Million in Private Placement, Issues Pre-Funded and 5-Year Warrants - TradingView
Bluejay Diagnostics (NASDAQ: BJDX) closes $8.5M warrant-backed financing - Stock Titan
Bluejay Diagnostics completes private placement that raised USD 8.5M - Medical Buyer
Bluejay Diagnostics closes $8.5 million private placement By Investing.com - Investing.com Australia
Bluejay Diagnostics closes $8.5 million private placement - Investing.com
Bluejay Diagnostics, Inc. Closes $8.5 Million Private Placement to Extend Cash Runway for FDA Approval and Commercialization - Moomoo
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance Australia
[SCHEDULE 13G] Bluejay Diagnostics, Inc. Passive Investment Disclosure (>5%) - Stock Titan
What's going on with Bluejay Diagnostics shares on Wednesday? - MSN
Bluejay Diagnostics, Inc. announced that it has received $8.500007 million in funding - marketscreener.com
BJDX Q4 2023 Earnings: Significant EPS Miss Despite Revenue Absence Drives Stock SurgeTech Earnings Analysis - newsline.com
What's Going On With Bluejay Diagnostics Shares On Wednesday? - Benzinga
Bluejay Diagnostics Forms U.S. Manufacturing Partnership for Symphony - The Globe and Mail
Bluejay Diagnostics raises $8.5M in private placement By Investing.com - Investing.com Australia
Bluejay Diagnostics, Argonaut Manufacturing Services join hands - Medical Buyer
Northstrive Fund II and Braeden Lichti exit Bluejay Diagnostics (BJDX) stake - Stock Titan
Large Bluejay Diagnostics (BJDX) holder reports full exit in 13G/A - Stock Titan
Bluejay's Domestic Pivot: De-Risking the Long Road to Market - BriefGlance
Bluejay Diagnostics Inc has disclosed a private placement plan with a maximum financing amount of $23.6 million. - Bitget
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Bluejay Diagnostics Stock Nearly Triples After U.S. Manufacturing Deal — Here’s the FDA Catch - TechStock²
Bluejay Diagnostics raises $8.5M in private placement - Investing.com
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times
Press Release: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Moomoo
Bluejay Diagnostics Partners with Argonaut Manufacturing to Advance U.S. Production of Symphony Platform for Critical Care Diagnostics 1 - Minichart
Bluejay Diagnostics, Argonaut Manufacturing Services Collaborate on Development of Symphony Testing Platform - Moomoo
Bluejay Diagnostics partners with Argonaut to boost US manufacturing for its Symphony™ diagnostic platform - Pluang
Bluejay Diagnostics surges 163% on strategic U.S. manufacturing partnership tied to Symphony platform - Quiver Quantitative
Why is Bluejay Diagnostics stock soaring Tuesday? - MSN
Trending Stocks Today | Decent Holding Soars 222.5% - Moomoo
BJDX Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bluejay Diagnostics Inc Stock (BJDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dey Indranil | President and CEO |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,522 |
| CHASE DONALD R | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,525 |
| ZEIDMAN FRED S | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,500 |
| Dey Svetlana | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,501 |
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):